Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The environmental impact of inhalers for asthma: A green challenge and a golden opportunity
Alex Wilkinson, Ashley Woodcock
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 7, pp. 3016-3022
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Recent developments in lactose blend formulations for carrier-based dry powder inhalation
Gerald A. Hebbink, Maarten Jaspers, Harry Peters, et al.
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114527-114527
Closed Access | Times Cited: 50
Patients' Attitudes Towards Integrating Environmental Sustainability Into Healthcare Decision‐Making: An Interview Study
Eva S Cohen, Dionne Kringos, Fleur Grandiek, et al.
Health Expectations (2025) Vol. 28, Iss. 1
Open Access
Healthcare exceptionalism: should healthcare be treated differently when it comes to reducing greenhouse gas emissions?
Joshua Parker
Medicine Health Care and Philosophy (2025)
Open Access
Harmonising green informed consent with autonomous clinical decision-making: a reply to Resnik and Pugh
Eva S Cohen, Dionne Kringos, Wouter Johan Karel Hehenkamp, et al.
Journal of Medical Ethics (2024) Vol. 50, Iss. 7, pp. 498-500
Closed Access | Times Cited: 4
Strategies and tactics to reduce the impact of healthcare on climate change: systematic review
Jeffrey Braithwaite, Carolynn L. Smith, Elle Leask, et al.
BMJ (2024), pp. e081284-e081284
Open Access | Times Cited: 4
Barriers to green inhaler prescribing: ethical issues in environmentally sustainable clinical practice
Joshua Parker
Journal of Medical Ethics (2022) Vol. 49, Iss. 2, pp. 92-98
Open Access | Times Cited: 22
Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
Mark L Levy, Eric D. Bateman, Keith Allan, et al.
The Lancet (2023) Vol. 402, Iss. 10406, pp. 1012-1016
Open Access | Times Cited: 13
Understanding the feasibility and environmental effectiveness of a pilot postal inhaler recovery and recycling scheme
Anna C Murphy, David Howlett, Aaron Gowson, et al.
npj Primary Care Respiratory Medicine (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 12
Physicians’ views of patient–planetary health co-benefit prescribing: a mixed methods systematic review
Nicole Redvers, Kyla Wright, Jamie Hartmann‐Boyce, et al.
The Lancet Planetary Health (2023) Vol. 7, Iss. 5, pp. e407-e417
Open Access | Times Cited: 10
Patient and Provider Perspectives Driving Inhaler Choice
Graham Lough, Sinthia Bosnic‐Anticevich, Nicolás Roche, et al.
CHEST Journal (2024) Vol. 166, Iss. 5, pp. 934-937
Open Access | Times Cited: 2
Update on the pharmacological treatment of chronic obstructive pulmonary disease
Madeleine R. Jacques, Brooks Kuhn, Timothy E. Albertson
Expert Opinion on Pharmacotherapy (2024), pp. 1-20
Open Access | Times Cited: 2
Carbon footprint modelling of national health systems: Opportunities, challenges and recommendations
Amy Booth
The International Journal of Health Planning and Management (2022) Vol. 37, Iss. 4, pp. 1885-1893
Open Access | Times Cited: 14
Bringing Environmental Sustainability into the Quality Agenda: Time to Act on Reducing Health Care Pollution and Waste
Jodi D. Sherman, Hardeep Singh
The Joint Commission Journal on Quality and Patient Safety (2023) Vol. 49, Iss. 6-7, pp. 336-339
Closed Access | Times Cited: 7
Optimizing the formulation variables for encapsulation of linezolid into polycaprolactone inhalable microspheres using double emulsion solvent evaporation
Yuwanshi Sharma, Riya Mahar, Arpita Chakraborty, et al.
Tuberculosis (2023) Vol. 143, pp. 102417-102417
Open Access | Times Cited: 5
Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials
Annette Kainu, Ville Vartiainen, Witold Mazur, et al.
Pulmonary Therapy (2024) Vol. 10, Iss. 1, pp. 133-142
Open Access | Times Cited: 1
Evaluating inhaler technique, patient preferences and opportunities for improvement in hospitals in the UK
Evie Rothwell, Joseph McElvaney, Alice Fitzpatrick, et al.
Future Healthcare Journal (2024) Vol. 11, Iss. 2, pp. 100141-100141
Open Access | Times Cited: 1
Patient autonomy in the era of the sustainability crisis
Szilárd Dávid Kovács
Medicine Health Care and Philosophy (2024) Vol. 27, Iss. 3, pp. 399-405
Open Access | Times Cited: 1
Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma
Boudewijn J.H. Dierick, Amber Eikholt, Susanne J. van de Hei, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 11, pp. 1507-1516
Closed Access | Times Cited: 1
Beyond the incubator: applying a “one health” approach in the NICU
Daniel O’Reilly, Alison C. Livada, Laurie A. Steiner, et al.
Pediatric Research (2024)
Open Access | Times Cited: 1
The environmental burden of inhalation
Anne H. de Boer
European Journal of Pharmaceutical Sciences (2024), pp. 106893-106893
Open Access | Times Cited: 1
Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London
Anna De Simoni, Hajar Hajmohammadi, Paul Pfeffer, et al.
British Journal of General Practice (2022) Vol. 72, Iss. 722, pp. e619-e626
Open Access | Times Cited: 7
Characteristics of asthma patients overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London – a cross-sectional observational study
Paul Pfeffer, Hajar Hajmohammadi, James Cole, et al.
BJGP Open (2023) Vol. 7, Iss. 2, pp. BJGPO.2023.0020-BJGPO.2023.0020
Open Access | Times Cited: 3
Towards net zero: asthma care
Laura‐Jane Smith, Ruhi Bhugra, Reem Y Kelani, et al.
BMJ (2023), pp. e072328-e072328
Open Access | Times Cited: 3
Patient perspectives on the environmental impact of inhalers: A survey in British Columbia
Darryl Quantz, Gigi Y.C. Wong, Kevin E. Liang
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (2023) Vol. 156, Iss. 6, pp. 298-302
Open Access | Times Cited: 3
Environmental risk of pharmaceuticals: Let us look at the whole package
Unax Lertxundi, Saioa Domingo‐Echaburu, Gorka Orive
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 8, pp. 3918-3919
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top